Residual risk in cardiovascular and renal diseases and the potential role of aldosterone synthase inhibitors - Poll - MDSpire

Residual risk in cardiovascular and renal diseases and the potential role of aldosterone synthase inhibitors

  • By

  • Kausik Umanath

  • Jamie P. Dwyer

  • Robert J. Mentz

  • May 29, 2026

  • 0 min

Share

Original Source(s)

Residual risk in cardiovascular and renal diseases and the potential role of aldosterone synthase inhibitors

  • by Kausik Umanath, Jamie P. Dwyer, Robert J. Mentz

  • May 29, 2026

Related Content

Prognostic value of CTI for major adverse cardiovascular events in patients With ST-elevation myocardial infarction after primary percutaneous coronary intervention

Publisher Correction: Rapid prediction of cardiac activation in the left ventricle with geometric deep learning: a step towards cardiac resynchronization therapy planning

Risk-score performance for detecting transthyretin cardiac amyloidosis in severe aortic stenosis: a prospective cohort study